| Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707) |
|---|
| 05/04/2006 | WO2006045963A2 Composition of cosmetic or pharmacological application for stimulation of synthesis of collagen |
| 05/03/2006 | EP1651342A2 Combinatorial synthesis on support |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1244454B1 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 04/26/2006 | CN1253473C Medicinal collagen material and its making process |
| 04/25/2006 | US7033605 performing an ocular transplant procedure; implanting in the eye a biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer. |
| 04/25/2006 | US7033604 Composition for topical administration |
| 04/20/2006 | WO2006042186A2 Gastrointestinal examination preparation |
| 04/20/2006 | US20060084614 Anticoagulants; bioavailability, lower toxicity; 1-(glycosyl substituted phenylmethylamino)-4-amidino-benzene derivatives |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/19/2006 | EP1294395B1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
| 04/12/2006 | EP1297116B1 Method for isolating and purifying a protein |
| 04/12/2006 | EP1233767B1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2006 | EP1140175B1 Antibodies to truncated vegf-d and uses thereof |
| 04/12/2006 | CN1250287C Application of recombinant adenovirus in treating cerebral ischemia, traumatic restoration and tissue adhesion |
| 04/11/2006 | US7025990 Methods for forming regional tissue adherent barriers and drug delivery systems |
| 04/05/2006 | EP1140192B1 Use of the cyclooxygenase-2 inhibitor celecoxib and capecitabine for combination therapy in neoplasia |
| 04/05/2006 | EP0991660B8 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 04/05/2006 | CN1248692C Use of corpus vitreum conjugated protein receptor antagon in preparation of medicine for inhibiting accretion generation |
| 04/04/2006 | US7022739 Substituted 1-aminobutan-3-ol compounds |
| 03/30/2006 | WO2006032144A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using fucans from various echinoderm sources |
| 03/30/2006 | WO2006032143A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| 03/30/2006 | US20060067932 Antagonists specific for denatured collagen and methods of using same |
| 03/30/2006 | CA2623471A1 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans |
| 03/29/2006 | CN1247583C Crystalline and amorphous form of triazolo (4,5-d) pyrimidine compound |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/22/2006 | CN1246047C A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7014838 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 03/15/2006 | EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/15/2006 | EP1318819A4 Treatment of trauma, and other indications |
| 03/15/2006 | EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound |
| 03/15/2006 | CN1245165C Preparation method and uses of hyaluronic acid gel with iron ion and medicine used for preventing adhesion after operation |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/09/2006 | US20060052389 Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 03/08/2006 | EP1267886B1 Vitamin d compounds for the treatment of chronic allograft nephropathy in kidney transplant patients |
| 03/07/2006 | US7008626 For use in resecting epithelium |
| 03/07/2006 | US7008444 Method of controlling body temperature while reducing shivering |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 02/28/2006 | US7005516 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005422 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/23/2006 | WO2005102319A3 Use of melatonin in preventing postoperative complications |
| 02/23/2006 | US20060040912 Compounds for pdt |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060034941 Organ preconditioning, arrest, protection, preservation and recovery |
| 02/16/2006 | US20060034892 Composition for topical administration |
| 02/15/2006 | CN1732898A Post-surgery anti-accretion material capable of gelatinized in situ or by injection and preparation process thereof |
| 02/15/2006 | CN1241909C Carboxylic acid derivatives as IP antagonists |
| 02/15/2006 | CN1241901C Perfluoronated cycle-containing tertiary amines used as basis for gas-conveying emulsions and preparation method |
| 02/15/2006 | CN1241570C Bile secretion promoting composition |
| 02/09/2006 | CA2638747A1 Combination drug therapy for reducing scar tissue formation |
| 02/08/2006 | CN1240688C Quinazoline compounds |
| 02/07/2006 | US6995182 1-sulfonyl pyrrolidine derivatives |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/26/2006 | US20060018844 Botulinum toxin dental therapy for angular cheilosis |
| 01/19/2006 | US20060014747 Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents |
| 01/19/2006 | US20060013812 Mixture comprising blood coagulation factor and serpin for use in prevention and treatment of blood disorders |
| 01/18/2006 | EP0828492B1 Medicaments for preventing intervention-associated stenosis following non-bypass, invasive interventions |
| 01/18/2006 | CN1237062C Ortho-substituted anthranilic acid amides and their use as medicaments |
| 01/17/2006 | US6986888 Method for treating mammals with modified mammalian blood |
| 01/12/2006 | US20060009527 Method of treating TRX mediated diseases |
| 01/12/2006 | US20060009526 Method of treating TRX mediated diseases |
| 01/05/2006 | US20060003932 Method for promoting neovascularization |
| 01/04/2006 | EP1212000B1 System for controlling body temperature while reducing shivering |
| 01/04/2006 | EP1149116B1 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 12/28/2005 | EP1609477A1 Irrigation solution and use thereof for the perioperative inhibition of pain/inflammation and/or spasm at a vascular structure |
| 12/28/2005 | EP0991660B1 DEUTERATED and undeuterated CYCLOSPORINE ANALOGS AND THEIR USE AS IMMUNOMODULATING AGENTS |
| 12/28/2005 | CN1233325C Drug for treatment of osteonecrosis and for management of patients at risk of steonecrosis |
| 12/22/2005 | WO2005097814A3 Composition and method for inhibiting platelet aggregation |
| 12/22/2005 | US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/21/2005 | EP1607102A1 Preventive for adhesion following abdominal surgery |
| 12/21/2005 | CN1232507C Growth hormone secretagogues |
| 12/14/2005 | EP1603579A2 Compositions and methods for use of alginate dural sealants |
| 12/14/2005 | EP1261583B1 INHIBITORS OF THE ICE/Ced-3 FAMILY OF CYSTEINE PROTEASES |
| 12/13/2005 | US6974813 For therapy of perioperative myocardial ischemic injury in mammals, including humans |
| 12/07/2005 | EP1368309B1 Thiol-modified hyaluronan |
| 12/01/2005 | US20050266533 Therapeutic fusion protein with enhanced for use in prevention and treatment of cell proliferative, blood and nervous system disorders |
| 12/01/2005 | US20050266532 Albumin fusion proteins |
| 11/30/2005 | EP1282439B1 PHARMACEUTICAL COMPOSITION COMPRISING A FACTOR VIIa AND A TFPI INHIBITOR |
| 11/30/2005 | CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation |
| 11/30/2005 | CN1703210A Formulation, which can be administered gastrointestinally, and uses thereof |
| 11/30/2005 | CN1229148C Adhesion preventing membrane and its preparing method |
| 11/24/2005 | US20050261343 Anthranilamides and their use as pharmaceutical agents |
| 11/23/2005 | CN1228050C Medicine for preventing tissue from adhesion after operation |
| 11/16/2005 | EP1368419B1 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 11/16/2005 | CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 11/16/2005 | CN1697647A Liquor and method for restraining ache, inflammation and cartilage degradation |
| 11/10/2005 | US20050250939 Process for the production of multiple cross-linked hyaluronic acid derivatives |
| 11/10/2005 | US20050249710 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides |
| 11/09/2005 | EP1328552A4 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 11/03/2005 | WO2005102319A2 Use of melatonin in preventing postoperative complications |
| 11/03/2005 | US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12 |